Moreover, genes involved in de novo lipogenesis, such as AKT2, SREBP1c, PPARγ, ACC, and FAS, are dramatically upregulated in HCV‐HCC compared to control liver, suggesting robust activation of de novo lipogenesis. Here, FAS is linked to hepatocellular carcinoma.